CTT Pharmaceutical CEO Ryan Khouri acquires CTTH shares worth $454.5

PUBT · 1d ago
CTT Pharmaceutical CEO Ryan Khouri acquires CTTH shares worth $454.5
  • CTT Pharmaceutical Holdings filed a Form 4 showing CEO Ryan Khouri bought 10,100 CTTH shares in open-market purchases.
  • The shares were acquired at USD 0.05 each.
  • His direct holdings rose to 1,056,800 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001035422-26-000013), on September 22, 2026, and is solely responsible for the information contained therein.